Skip to content

Opening book details…

About this Medicine article

Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer by Katakami, Nobuyuki; Hida, Toyoaki; Nokihara, Hiroshi; Imamura, Fumio; Sakai, Hiroshi; Atagi, Shinji; Nishio, Makoto; Kashii, Tatsuhiko; Satouchi, Miyako; Helwig, Christoph; Watanabe, Morihiro; Tamura, Tomohide is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Katakami, Nobuyuki; Hida, Toyoaki; Nokihara, Hiroshi; Imamura, Fumio; Sakai, Hiroshi; Atagi, Shinji; Nishio, Makoto; Kashii, Tatsuhiko; Satouchi, Miyako; Helwig, Christoph; Watanabe, Morihiro; Tamura, Tomohide
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
Published
2017
Field
Medicine (Health Sciences)

More by Katakami, Nobuyuki; Hida, Toyoaki; Nokihara, Hiroshi; Imamura, Fumio; Sakai, Hiroshi; Atagi, Shinji; Nishio, Makoto; Kashii, Tatsuhiko; Satouchi, Miyako; Helwig, Christoph; Watanabe, Morihiro; Tamura, Tomohide

Browse all works by Katakami, Nobuyuki; Hida, Toyoaki; Nokihara, Hiroshi; Imamura, Fumio; Sakai, Hiroshi; Atagi, Shinji; Nishio, Makoto; Kashii, Tatsuhiko; Satouchi, Miyako; Helwig, Christoph; Watanabe, Morihiro; Tamura, Tomohide